Taurus Vascular Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

Taurus Vascular General Information

Description

Developer of a medical device company designed to transform the standard of care for patients with aortic aneurysms. The company is developing a novel medical device technology to eliminate the negative effects of endoleaks and facilitate accelerated aneurysm sac shrinkage after endovascular aortic aneurysm repair (EVAR), enabling the healthcare industry to improve patient outcomes and better long-term patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2450 Holcombe Boulevard
  • Suite CDI
  • Houston, TX 77021
  • United States
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Corporate Office
  • 2450 Holcombe Boulevard
  • Suite CDI
  • Houston, TX 77021
  • United States

Taurus Vascular Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Taurus Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 29-May-2024 Completed Pre-Clinical Trials
5. Accelerator/Incubator 22-May-2024 Completed Pre-Clinical Trials
4. Seed Round 01-Mar-2024 Completed Pre-Clinical Trials
3. Accelerator/Incubator 26-Jul-2023 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-May-2023 $300K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2022 $300K $300K Completed Pre-Clinical Trials
To view Taurus Vascular’s complete valuation and funding history, request access »

Taurus Vascular Patents

Taurus Vascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026024887-A1 Methods and systems for robotic transcaval treatment of aneurysms Pending 24-Jul-2024
US-12310837-B1 Methods and systems for transcaval treatment of aneurysms Active 24-Jul-2024
US-20250262044-A1 Methods and systems for transcaval treatment of aneurysms Pending 24-Jul-2024
WO-2025160095-A1 Methods and systems for transcaval treatment of aneurysms Pending 22-Jan-2024
US-12318563-B1 Methods and systems for transcaval treatment of aneurysms Active 02-Feb-2021 A61M27/002
To view Taurus Vascular’s complete patent history, request access »

Taurus Vascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Taurus Vascular Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Texas A&M New Ventures Competition University Minority
MassChallenge Accelerator/Incubator
OwlSpark Accelerator/Incubator Minority
Texas Medical Center Venture Capital Minority
To view Taurus Vascular’s complete investors history, request access »

Taurus Vascular FAQs

  • When was Taurus Vascular founded?

    Taurus Vascular was founded in 2022.

  • Where is Taurus Vascular headquartered?

    Taurus Vascular is headquartered in Houston, TX.

  • What is the size of Taurus Vascular?

    Taurus Vascular has 3 total employees.

  • What industry is Taurus Vascular in?

    Taurus Vascular’s primary industry is Surgical Devices.

  • Is Taurus Vascular a private or public company?

    Taurus Vascular is a Private company.

  • What is Taurus Vascular’s current revenue?

    The current revenue for Taurus Vascular is .

  • How much funding has Taurus Vascular raised over time?

    Taurus Vascular has raised $1.83M.

  • Who are Taurus Vascular’s investors?

    MedTech Innovator, Texas A&M New Ventures Competition, MassChallenge, OwlSpark, and Texas Medical Center have invested in Taurus Vascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process